Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Pharmacokinetics of a single dose of teicoplanin in burn patients.

Steer JA, Papini RP, Wilson AP, Dhillon S, Hichens MF, McGrouther DA, Frame JD, Parkhouse N.

J Antimicrob Chemother. 1996 Mar;37(3):545-53.

PMID:
9182111
2.

Antibiotic prophylaxis in cardiac surgery: factors associated with potentially toxic serum concentrations of gentamicin.

Heylen RM, Wilson AP, Hichens M, Felmingham D, Webb A, Pattison CW, Pugsley W.

J Antimicrob Chemother. 1995 May;35(5):657-67.

PMID:
7592179
3.

Clearance of gentamicin during cardiac surgery.

Heylen RM, Wilson AP, Hichens M, Felmingham D, Webb A, Pattison CW, Pugsley W.

J Antimicrob Chemother. 1995 May;35(5):649-55.

PMID:
7592178
4.

Determination of MK-383, a non-peptide fibrinogen receptor antagonist, in human plasma and urine by radioimmunoassay.

Hand EL, Gilbert JD, Yuan AS, Olah TV, Hichens M.

J Pharm Biomed Anal. 1994 Aug;12(8):1047-53.

PMID:
7819379
5.

Determination of L-691,121, a new class III antiarrhythmic, and its principal metabolite in plasma by differential radioimmunoassay.

Greber TF, Olah TV, Gilbert JD, Porras AG, Hichens M.

J Pharm Biomed Anal. 1994 Apr;12(4):483-92.

PMID:
7918764
6.

Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.

Lin JH, Chen IW, deLuna FA, Hichens M.

J Pharmacol Exp Ther. 1993 Nov;267(2):670-5.

PMID:
8246140
7.

Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay.

Yuan AS, Hand EL, Hichens M, Olah TV, Barrish A, Fernandez-Metzler C, Gilbert JD.

J Pharm Biomed Anal. 1993 Jun;11(6):427-34.

PMID:
8399513
8.

The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid.

Green SD, Ilunga F, Cheesbrough JS, Tillotson GS, Hichens M, Felmingham D.

J Infect. 1993 May;26(3):253-6.

PMID:
8505559
9.

In vivo and in vitro metabolism studies on a class III antiarrhythmic agent.

Vickers S, Duncan CA, Kari PH, Homnick CF, Elliott JM, Pitzenberger SM, Hichens M, Vyas KP.

Drug Metab Dispos. 1993 May-Jun;21(3):467-73.

PMID:
8100503
10.

Renal handling of alendronate in rats. An uncharacterized renal transport system.

Lin JH, Chen IW, Deluna FA, Hichens M.

Drug Metab Dispos. 1992 Jul-Aug;20(4):608-13.

PMID:
1356743
11.

Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primates.

Alexander GM, Brainard DL, Gordon SW, Hichens M, Grothusen JR, Schwartzman RJ.

Brain Res. 1991 May 3;547(2):181-9.

PMID:
1679365
12.
13.

Metabolism of antiparkinson agent dopazinol by rat liver microsomes.

Vyas KP, Kari PH, Ramjit HG, Pitzenberger SM, Hichens M.

Drug Metab Dispos. 1990 Nov-Dec;18(6):1025-30.

PMID:
1981508
14.

A radioimmunoassay for the anticonvulsant and neuroprotective agent, MK-801.

Hichens M, Greber TF, Vyas KP.

J Immunoassay. 1990;11(4):477-502.

PMID:
2283390
15.

Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery.

Morran C, McArdle C, Pettitt L, Sleigh D, Gemmell C, Hichens M, Felmingham D, Tillotson G.

Am J Med. 1989 Nov 30;87(5A):86S-88S. No abstract available.

PMID:
2589392
16.

Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers.

Beermann B, Till AE, Gomez HJ, Hichens M, Bolognese JA, Junggren I.

Biopharm Drug Dispos. 1989 Jul-Aug;10(4):397-409.

PMID:
2547465
17.

Antiparkinsonian efficacy of a novel transdermal delivery system for (+)-PHNO in MPTP-treated squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Hand E, Iversen SD, Stahl SM.

Neurology. 1989 Mar;39(3):329-35.

PMID:
2784549
18.

Therapeutic efficacy of a novel transdermal delivery system for (+)-PHNO in parkinsonian squirrel monkeys.

Rupniak NM, Tye SJ, Jennings CA, Loper AE, Bondi JV, Hichens M, Iversen SD, Stahl SM.

J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):289-90. No abstract available.

19.

The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.

Till AE, Dickstein K, Aarsland T, Gomez HJ, Gregg H, Hichens M.

Br J Clin Pharmacol. 1989 Feb;27(2):199-204.

20.

The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.

Coleman RJ, Lange KW, Quinn NP, Loper AE, Bondi JV, Hichens M, Stahl SM, Marsden CD.

Mov Disord. 1989;4(2):129-38.

PMID:
2733705
21.

The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure.

Dickstein K, Till AE, Aarsland T, Tjelta K, Abrahamsen AM, Kristianson K, Gomez HJ, Gregg H, Hichens M.

Br J Clin Pharmacol. 1987 Apr;23(4):403-10.

22.

Radioimmunoassays for the enantiomeric components of indacrinone and their phenolic metabolites.

Vyas KP, Hichens M, Mulcahy WS, Hand EL.

J Immunoassay. 1987;8(2-3):179-201.

PMID:
3624493
23.

Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.

Hughes JM, Hichens M, Booze GW, Thorner MO.

Arch Intern Med. 1986 Sep;146(9):1848-9.

PMID:
3753129
24.

The effect of renal function on enalapril kinetics.

Lowenthal DT, Irvin JD, Merrill D, Saris S, Ulm E, Goldstein S, Hichens M, Klein L, Till A, Harris K.

Clin Pharmacol Ther. 1985 Dec;38(6):661-6.

PMID:
2998676
26.

Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.

Vlasses PH, Ribeiro LG, Rotmensch HH, Bondi JV, Loper AE, Hichens M, Dunlay MC, Ferguson RK.

J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):245-50.

PMID:
2581075
27.

Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteers.

Till AE, Gomez HJ, Hichens M, Bolognese JA, McNabb WR, Brooks BA, Noormohamed F, Lant AF.

Biopharm Drug Dispos. 1984 Jul-Sep;5(3):273-80.

PMID:
6091806
28.

L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.

Williams M, Martin GE, Remy DC, Hichens M, Mangel AW, Taylor DA, Yarbrough GG, Bendesky RJ, King SW, Robinson JL, et al.

J Pharmacol Exp Ther. 1984 Jun;229(3):775-81.

PMID:
6547178
29.

Inhibitor binding assay for angiotensin-converting enzyme.

Fyhrquist F, Tikkanen I, Grönhagen-Riska C, Hortling L, Hichens M.

Clin Chem. 1984 May;30(5):696-700.

30.

Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans.

Rotmensch HH, Vincent M, Vlasses PH, Swanson BN, Irvin JD, Hichens M, Harris KE, Ferguson RK.

Fed Proc. 1984 Apr;43(5):1333-5.

PMID:
6323225
31.

The effect of enalapril on serum prolactin.

McNabb WR, Brooks BA, Noormohamed F, Lant AF, Gomez HJ, Cirillo VJ, Hichens M, Bolognese JA.

Br J Clin Pharmacol. 1983 Jun;15(6):752-4.

32.

A comparison of thyrotropin-releasing hormone with analogs: influence of disposition upon pharmacology.

Hichens M.

Drug Metab Rev. 1983;14(1):77-98. No abstract available.

PMID:
6301791
33.

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ.

Br J Clin Pharmacol. 1982 Sep;14(3):363-8.

34.

Enalapril maleate and a lysine analogue (MK-521): disposition in man.

Ulm EH, Hichens M, Gomez HJ, Till AE, Hand E, Vassil TC, Biollaz J, Brunner HR, Schelling JL.

Br J Clin Pharmacol. 1982 Sep;14(3):357-62.

35.

Effects of enalapril, a new converting enzyme inhibitor, in hypertension.

Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB.

Clin Pharmacol Ther. 1982 Jul;32(1):48-53.

PMID:
6282527
36.

Biological activities of a new steroidal inhibitor of delta 4-5 alpha-reductase.

Brooks JR, Berman C, Hichens M, Primka RL, Reynolds GF, Rasmusson GH.

Proc Soc Exp Biol Med. 1982 Jan;169(1):67-73. No abstract available.

PMID:
7063497
37.

Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.

Brooks JR, Baptista EM, Berman C, Ham EA, Hichens M, Johnston DB, Primka RL, Rasmusson GH, Reynolds GF, Schmitt SM, Arth GE.

Endocrinology. 1981 Sep;109(3):830-6. No abstract available.

PMID:
7262023
38.

Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.

Swanson BN, Hichens M, Mojaverian P, Ferguson RK, Vlasses PH, Dudash M.

Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):525-36.

PMID:
6276950
39.

Effect of hypophysectomy, prolactin, and prostaglandin F2 alpha on gonadotropin binding in vivo and in vitro in the corpus luteum.

Behrman HR, Grinwich DL, Hichens M, MacDonald GJ.

Endocrinology. 1978 Aug;103(2):349-57. No abstract available.

PMID:
217643
40.

Analysis of sulindac and metabolites by combined isotope dilution-radioimmunoassay.

Hare LE, Ditzler CA, Hichens M, Rosegay A, Duggan DE.

J Pharm Sci. 1977 Mar;66(3):414-7.

PMID:
321751
41.

Rapid block of gonadotropin uptake by corpora lutea in vivo induced by prostaglandin F2alpha.

Behrman HR, Hichens M.

Prostaglandins. 1976 Jul;12(1):83-95.

PMID:
959580
42.

Serum profiles of luteinizing hormone, progesterone and total estrogens during the canine estrous cycle.

Mellin TN, Orczyk GP, Hichens M, Behrman HR.

Theriogenology. 1976 Apr;5(4):175-87. No abstract available.

PMID:
985766
43.

Chemical inhibition of estrus in the beagle.

Mellin TN, Orczyk GP, Hichens M, Behrman HR.

Theriogenology. 1976 Apr;5(4):165-74. No abstract available.

PMID:
985765
44.

Control of the LH receptor by prolactin and prostaglandin F2alpha in rat corpora lutea.

Grinwich DL, Hichens M, Behrman HR.

Biol Reprod. 1976 Mar;14(2):212-8. No abstract available.

PMID:
177110
45.

Studies of a glycoprotein in the oocysts of Eimeria tenella.

Stotish RL, Wang CC, Hichens M, VandenHeuvel WJ, Gale P.

J Biol Chem. 1976 Jan 25;251(2):302-7.

46.

Studies on the mechanism of PGF2alpha and gonadotropin interactions on LH receptor function in corpora lutea during luteolysis.

Behrman HR, Grinwich DL, Hichens M.

Adv Prostaglandin Thromboxane Res. 1976;2:655-66.

PMID:
185887
48.

PGF-2 alpha-induced loss of corpus luteum gonadotrophin receptors.

Hichens M, Grinwich DL, Behman HR.

Prostaglandins. 1974 Sep 25;7(6):449-58. No abstract available.

PMID:
4370306
49.

Radioimmunoassay for dexamethasone in plasma.

Hichens M, Hogans AF.

Clin Chem. 1974 Feb;20(2):266-71. No abstract available.

50.

Specific cleavage of the A1 protein from myelin with cathepsin D.

Brostoff SW, Reuter W, Hichens M, Eylar EH.

J Biol Chem. 1974 Jan 25;249(2):559-67. No abstract available.

Supplemental Content

Loading ...
Support Center